Jbklab Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2039
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Sep 22 US 12,741,029 Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,465,627 | Immunity-boosting agent, immuno-therapeutic anti-cancer agent, and anti-cancer therapy adverse effect mitigating agent containing anthocyanin-fucoidan complex as active ingredient In force · USPTO record | In force | USPTO record | |
| US 12,195,467 | Compound Having Trka Inhibitory Activity and Pharmaceutical Composition, for Preventing or Alleviating Pain, Containing Same as Active Ingredient In force · High confidence | In force | High confidence | |
| US 12,507,720 | Use of anthocyanin-anionic polysaccharide complex for preventing or treating influenza virus A infection In force · USPTO record | In force | USPTO record | |
| US 12,605,382 | Pharmaceutical Composition for Preventing, Alleviating, or Treating Cancer, Containing 2,6-Dichloro-4-(4-(4-hydroxycyclohexylamino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenol as Active Ingredient In force · High confidence | In force | High confidence | |
| US 12,741,029 | Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 no status recorded
Showing 1 to 2 of 2, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/289,280 | Pharmaceutical Composition for Prevention, Alleviation, or Treatment of Cancer | May 3, 2022 | Pending |
| 16/759,364 | Oct 26, 2018 | No status recorded |